Table 2.
Health care resource utilization over 1 year of follow-up
| Outcomes | GLA + RAI (n = 373) |
PMX (n = 373) |
P-value |
|---|---|---|---|
| Total health care utilization | |||
| Any hospitalization, n (%) | 90 (24.13) | 80 (21.45) | 0.3828 |
| Hospitalizations, n (SD) | 0.33 (0.74) | 0.32 (0.77) | 0.9228 |
| Hospitalization days, n (SD) | 1.91 (7.93) | 2.47 (7.79) | 0.3260 |
| Any ED visit, n (%) | 127 (34.05) | 122 (32.71) | 0.6979 |
| ED visits, n (SD) | 0.76 (1.87) | 0.79 (2.27) | 0.8189 |
| Any office visit, n (%) | 373 (100.00) | 372 (99.73) | 0.3170 |
| Office visits, n (SD) | 19.75 (14.25) | 20.32 (16.38) | 0.6133 |
| Any endocrinologist visit, n (%) | 171 (45.84) | 162 (43.43) | 0.5074 |
| Endocrinologist visits, n (SD) | 1.78 (2.49) | 1.70 (2.56) | 0.6740 |
| Diabetes-related health care utilization | |||
| Any hospitalization, n (%) | 84 (22.52) | 73 (19.57) | 0.3232 |
| Hospitalizations, n (SD) | 0.29 (0.68) | 0.28 (0.66) | 0.7845 |
| Hospitalization days, n (SD) | 1.60 (5.77) | 2.15 (7.05) | 0.2422 |
| Any ED visit, n (%) | 90 (24.13) | 89 (23.86) | 0.9317 |
| ED visits, n (SD) | 0.34 (0.77) | 0.39 (0.87) | 0.4480 |
| Any office visit, n (%) | 373 (100.00) | 370 (99.20) | 0.0826 |
| Office visits, n (SD) | 8.79 (5.36) | 8.94 (6.40) | 0.7192 |
Abbreviations: GLA, insulin glargine; RAI, rapid-acting insulin; PMX, premixed insulin; SD, standard deviation; ED, emergency department.